JNJ vs MIRA

Johnson & Johnson vs MIRA Pharmaceuticals, Inc. — Valuation Comparison 2026

JNJ

Drug Manufacturers - General
Johnson & Johnson
Quality
9.7
out of 10
Value Trap
17
SAFE
Price
$230.80
Last close
Models
12/13
Active
VS

MIRA

Drug Manufacturers - General
MIRA Pharmaceuticals, Inc.
Quality
4.3
out of 10
Value Trap
12
SAFE
Price
$1.08
Last close
Models
11/13
Active

Model-by-Model Comparison

ModelType JNJ Fair ValueJNJ Upside MIRA Fair ValueMIRA Upside
Bayesian DCF Intrinsic $76.94 -66.7% $0.35 -67.6%
Earnings Power Value Intrinsic $50.60 -78.1% $0.07 -93.0%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for JNJ vs MIRA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

JNJ vs MIRA — Which Stock Is More Undervalued?

JNJ scores higher with a 9.7/10 quality rating vs MIRA's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Johnson & Johnson (JNJ) and MIRA Pharmaceuticals, Inc. (MIRA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

JNJ currently trades at $230.80 with a QOC of 9.7/10, while MIRA trades at $1.08 with a QOC of 4.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).